2m 2m 2m 2m 2m 2m 2m
SEPTERNA (SEPN)
NASDAQ
$31.98-$2.38 (-6.94%)
Price as of Jul 13, 2026 7:58 PM EDT- $1.6BMarket Cap
- 186.09%1-Year Change
- BiotechnologyIndustry
SEPTERNA (SEPN)
$31.98-$2.38 (-6.94%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 15.52% | 7.0M | 0 (0.00%) | Mar 31, 2026 |
TRV GP V, LLC | 13.79% | 6.2M | 0 (0.00%) | Mar 31, 2026 |
DRIEHAUS CAPITAL MANAGEMENT LLC | 9.75% | 4.4M | -413,898 (-9.42%) | Mar 31, 2026 |
TRV GP VI, LLC | 9.34% | 4.2M | 0 (0.00%) | Mar 31, 2026 |
SAMSARA BIOCAPITAL, LLC | 6.99% | 3.1M | 0 (0.00%) | Mar 31, 2026 |
GOLDMAN SACHS GROUP INC | 6.45% | 2.9M | +191,298 (+6.58%) | Mar 31, 2026 |
SIREN, L.L.C. | 4.44% | 2.0M | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 2.59% | 1.2M | +11,627 (+1.00%) | Mar 31, 2026 |
PRIMECAP Odyssey Funds | 1.80% | 812,982 | +361,082 (+44.41%) | Apr 30, 2026 |
DRIEHAUS MUTUAL FUNDS | 1.19% | 537,006 | -123,859 (-23.06%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 0.78% | 353,200 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.61% | 276,108 | +249,579 (+90.39%) | Apr 30, 2026 |
Fidelity Rutland Square Trust II | 0.40% | 181,700 | 0 (0.00%) | Feb 28, 2026 |
FIDELITY ADVISOR SERIES VII | 0.29% | 130,200 | 0 (0.00%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions223.4M (88.72%)
- Mutual Funds27.1M (10.76%)
- Insiders1.3M (0.51%)
- Other0 (0.00%)
Insider Transactions
- 0.51% (1.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $15.3MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Shaikhly Samira Chief People Officer | Exempt | Jun 29, 2026 | $0.00 | 2,178 | $0.00 | 20,865 |
Shaikhly Samira Chief People Officer | Exempt | Jun 29, 2026 | $14,832.18 | 2,178 | $6.81 | 2,971 |
Shaikhly Samira Chief People Officer | Sell | Jun 29, 2026 | $76,622.04 | 2,178 | $35.18 | 793 |
Tong Jeffrey K | Award | Jun 26, 2026 | $0.00 | 15,000 | $0.00 | 15,000 |
RA CAPITAL MANAGEMENT, LLC | Award | Jun 26, 2026 | $0.00 | 15,000 | $0.00 | 15,000 |
Simson Jake | Award | Jun 26, 2026 | $0.00 | 15,000 | $0.00 | 15,000 |
Coulie Bernard | Award | Jun 26, 2026 | $0.00 | 15,000 | $0.00 | 15,000 |
Shaikhly Samira Chief People Officer | Exempt | Mar 02, 2026 | $0.00 | 53,714 | $0.00 | 15,969 |
Shaikhly Samira Chief People Officer | Exempt | Mar 02, 2026 | $0.00 | 11,638 | $0.00 | 3,460 |
Shaikhly Samira Chief People Officer | Exempt | Mar 02, 2026 | $0.00 | 5,101 | $0.00 | 5,101 |
Shaikhly Samira Chief People Officer | Exempt | Mar 02, 2026 | $83,256.70 | 53,714 | $1.55 | 54,507 |
Shaikhly Samira Chief People Officer | Exempt | Mar 02, 2026 | $32,120.88 | 11,638 | $2.76 | 66,145 |
Shaikhly Samira Chief People Officer | Exempt | Mar 02, 2026 | $14,078.76 | 5,101 | $2.76 | 71,246 |
Shaikhly Samira Chief People Officer | Sell | Mar 02, 2026 | $112,496.27 | 4,090 | $27.51 | 67,156 |
Shaikhly Samira Chief People Officer | Sell | Mar 02, 2026 | $1.9M | 66,363 | $28.14 | 793 |
Bhatt Elizabeth President and COO | Exempt | Feb 18, 2026 | $0.00 | 4,000 | $0.00 | 88,911 |
Bhatt Elizabeth President and COO | Exempt | Feb 18, 2026 | $27,240.00 | 4,000 | $6.81 | 178,209 |
Bhatt Elizabeth President and COO | Sell | Feb 18, 2026 | $62,610.68 | 2,200 | $28.46 | 176,009 |
Bhatt Elizabeth President and COO | Sell | Feb 18, 2026 | $53,249.58 | 1,800 | $29.58 | 174,209 |
Bhatt Elizabeth President and COO | Award | Feb 06, 2026 | $0.00 | 155,000 | $0.00 | 155,000 |
Kim Jae B. Chief Medical Officer | Award | Feb 06, 2026 | $0.00 | 125,000 | $0.00 | 125,000 |
Long Daniel D. SVP, Drug Discovery | Award | Feb 06, 2026 | $0.00 | 80,000 | $0.00 | 80,000 |
Shaikhly Samira Chief People Officer | Award | Feb 06, 2026 | $0.00 | 80,000 | $0.00 | 80,000 |
Finer Jeffrey Chief Executive Officer | Award | Feb 06, 2026 | $0.00 | 400,000 | $0.00 | 400,000 |
Klein Uwe SVP, Biological Sciences | Award | Feb 06, 2026 | $0.00 | 80,000 | $0.00 | 80,000 |
Long Daniel D. SVP, Drug Discovery | Sell | Nov 10, 2025 | $63,223.16 | 3,501 | $18.06 | 92,911 |
Gottesdiener Keith Michael | Award | Sep 25, 2025 | $0.00 | 33,246 | $0.00 | 33,246 |
Klein Uwe SVP, Biological Sciences | Exempt | Aug 18, 2025 | $0.00 | 10,452 | $0.00 | 10,453 |
Klein Uwe SVP, Biological Sciences | Exempt | Aug 18, 2025 | $0.00 | 4,935 | $0.00 | 9,001 |
Klein Uwe SVP, Biological Sciences | Exempt | Aug 18, 2025 | $0.00 | 7,621 | $0.00 | 33,027 |